Biotricity Inc Stock News

Company to announce continued Revenue Growth, Improvements in Margins, Operational Efficiency, and a shift to positive EBITDA

The Purpose Bitcoin Yield ETF (BTCY:CA) generates income by writing call options on Bitcoin, sacrificing some upside for current yield. This strategy suits investors seeking income from Bitcoin, but not those focused on maximizing capital appreciation from BTC's price growth. BTCY:CA offers a high distribution yield (around 17.7%), but comes with significant volatility and liquidity concerns, i...

Biotricity, Inc. (OTC:BTCY) Q4 2025 Earnings Call July 18, 2025 4:45 PM ET Company Participants S. John Ayanoglou - Chief Financial Officer Waqaas Al-Siddiq - Founder, President, CEO & Chairman Conference Call Participants Michael John Donovan - H.C.

REDWOOD CITY, CA, July 17, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company that offers innovative diagnostic, chronic disease, and lifestyle management solutions for healthcare providers and consumers, today announced its financial results for the fourth quarter and fiscal year ended March 31, 2025.

Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, will host its Fisc...

REDWOOD CITY, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY) a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease management solutions for healthcare providers and consumers, is proud to announce its inclusion on the Financial Times' list of The Americas' Fastest-Growing Companies 2025 . This recognition highlight...

Biotricity's latest patents focus on a multi-biometric device platform that functions as both a patch and watch, advancing biometric monitoring solutions for remote patient care.

REDWOOD CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB: BTCY) (“Biotricity” or the “Company”), a top Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today announced its financial results for the third quarter of fiscal 2025 year and (unaudited) ended December 31, 2024.